Is there still a role for computed tomography and bone scintigraphy in prostate cancer staging? An analysis from the EUREKA-1 database

Creators: Gabriele, D; Collura, D; Oderda, M; Stura, I; Fiorito, C; Porpiglia, F; Terrone, C; Zacchero, M; Guiot, C; Gabriele, P

Others:: Gabriele, D; Collura, D; Oderda, M; Stura, I; Fiorito, C; Porpiglia, F; Terrone, C; Zacchero, M; Guiot, C; Gabriele, P

Description

According to the current guidelines, computed tomography (CT) and bone scintigraphy (BS) are optional in intermediate-risk and recommended in high-risk prostate cancer (PCa). We wonder whether it is time for these examinations to be dismissed, evaluating their staging accuracy in a large cohort of radical prostatectomy (RP) patients.

Is there still a role for computed tomography and bone scintigraphy in prostate cancer staging? An analysis from the EUREKA-1 database

Description

Additional details